Forkhead box protein R2 (FOXR2)

Forkhead box protein R2 (FOXR2) is a member of the forkhead box (FOX) family of transcription factors, characterized by a conserved forkhead DNA-binding domain and mainly localized in the nucleoplasm[1][2][5][7]. In humans, FOXR2 is encoded by a single gene on the X chromosome (Xp11.21) with expression physiologically restricted to the testis, but it is aberrantly overexpressed in a wide range of malignancies, where it acts as an oncogene. FOXR2’s oncogenic functions include enhancement of cell proliferation, inhibition of apoptosis, increased metastatic potential, and modulation of multiple oncogenic signaling pathways, including MYC, Wnt/β-catenin, and ETS transcription circuitries. Its pivotal role in many cancers makes FOXR2 both a potential prognostic biomarker and an emerging but largely unexplored therapeutic target[1][6]. If more structured or up-to-date information becomes available, particularly regarding direct drug interactions or specific biomarker use in clinical trials, those sections can be expanded.

Other names

Forkhead box protein N6FOXN6MGC21658forkhead box R2forkhead box protein N6FOXR2

No approved drugs directly targeting FOXR2, but theoretical mechanisms include inhibition of its transcription factor activity or downstream pathways